Edgestream Partners L.P. bought a new position in shares of Dolby Laboratories (NYSE:DLB – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 24,176 shares of the electronics maker’s stock, valued at approximately $1,421,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Fulcrum Asset Management LLP raised its holdings in Dolby Laboratories by 733.7% in the 3rd quarter. Fulcrum Asset Management LLP now owns 1,434 shares of the electronics maker’s stock valued at $83,000 after acquiring an additional 1,262 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Dolby Laboratories by 130.1% in the third quarter. Nisa Investment Advisors LLC now owns 1,452 shares of the electronics maker’s stock worth $85,000 after purchasing an additional 821 shares during the period. Nykredit A S bought a new position in Dolby Laboratories in the second quarter valued at approximately $101,000. Hantz Financial Services Inc. increased its stake in shares of Dolby Laboratories by 86.0% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,557 shares of the electronics maker’s stock valued at $150,000 after purchasing an additional 1,182 shares during the last quarter. Finally, Covestor Ltd raised its stake in Dolby Laboratories by 90.4% during the third quarter. Covestor Ltd now owns 3,853 shares of the electronics maker’s stock worth $226,000 after acquiring an additional 1,829 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.
Insider Activity
In other news, CAO Ryan Nicholson sold 1,183 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the sale, the chief accounting officer directly owned 34,453 shares in the company, valued at $2,249,091.84. This trade represents a 3.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP John Couling sold 7,667 shares of the business’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares of the company’s stock, valued at $9,804,680.34. The trade was a 4.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 16,517 shares of company stock valued at $995,963. 37.93% of the stock is currently owned by company insiders.
Dolby Laboratories Stock Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.05. The firm had revenue of $373.54 million for the quarter, compared to analysts’ expectations of $372.76 million. Dolby Laboratories had a return on equity of 11.77% and a net margin of 18.14%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.99 EPS. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. Research analysts predict that Dolby Laboratories will post 3.36 EPS for the current fiscal year.
Dolby Laboratories declared that its Board of Directors has authorized a share repurchase program on Thursday, July 30th that permits the company to buy back $350 million in shares. This buyback authorization permits the electronics maker to repurchase up to 7% of its shares through open market purchases. Share buyback programs are typically a sign that the company’s board of directors believes its shares are undervalued.
Dolby Laboratories Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 9th. Stockholders of record on Tuesday, December 1st will be given a dividend of $0.39 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.8%. Dolby Laboratories’s payout ratio is currently 53.33%.
Analyst Ratings Changes
Several analysts have recently weighed in on DLB shares. Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Rosenblatt Securities decreased their price objective on Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating for the company in a report on Monday, November 16th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Research upgraded Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, November 13th. Finally, Robert W. Baird decreased their price target on Dolby Laboratories from $62.00 to $60.00 and set a “neutral” rating for the company in a research note on Thursday. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Hold” and a consensus price target of $76.67.
View Our Latest Stock Analysis on Dolby Laboratories
About Dolby Laboratories
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Recommended Stories
- Five stocks we like better than Dolby Laboratories
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
